Join the Campaign

Specialty Pharmacy

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
February 13, 2017
February 13, 2017
Health systems are increasingly turning to pharmacogenomics as a way to enhance therapeutic decision-making. At the 2016 American Heart Association'...
Health systems are increasingly turning to pharmacogenomics as a way to enhance therapeutic decision-making. At the 2016 American Heart Association's Scientific Sessions, Larisa H.
MORE
February 13, 2017
February 13, 2017
Sen. Chuck Grassley (R-IA), chairman of the Senate Judiciary Committee, has opened an inquiry into potential abuses of the Orphan Drug Act that may...
Sen. Chuck Grassley (R-IA), chairman of the Senate Judiciary Committee, has opened an inquiry into potential abuses of the Orphan Drug Act that may have contributed to high prices on commonly used drugs.
MORE
February 13, 2017
February 13, 2017
Marathon Pharmaceuticals will charge $89,000 annually for its Duchenne muscular dystrophy (DMD) drug in the United States. The drug, deflazacort,...
Marathon Pharmaceuticals will charge $89,000 annually for its Duchenne muscular dystrophy (DMD) drug in the United States. The drug, deflazacort, has been available in Europe for years at just a fraction of that cost.
MORE
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
January 31, 2017
January 31, 2017
As part of the Senate’s confirmation process for President Donald J. Trump’s nominee for Secretary of the U.S. Department of Health & Human...
Price: ‘Paying pharmacists in underserved areas to engage in certain medical services could work well’
MORE
January 24, 2017
The official renewal of our untiring quest for pharmacist provider status recognition in the 115th Congress has begun: the Pharmacy and Medically...
MORE
January 23, 2017
January 23, 2017
Following on the heels of the provider status bill that was reintroduced in the Senate on Jan. 12, members of the U.S House of Representatives...
Senate companion bill was reintroduced earlier in January
MORE
Advertisement